News

Novel validation and experimentation services for SMEs for AI and robotics-based healthcare solutions

Published on | 2 weeks ago

Programmes
Health EIT AI Continent

The Testing and Experimentation Facility for Health AI and Robotics (TEF-Health) has opened a call offering SMEs discounted access to novel validation and experimentation services for health AI and robotic solutions. Through TEF-Health, SMEs can work with European research centres, hospitals, universities and certification bodies to test AI and robotics solutions using high-quality data and real clinical environments, helping prepare products for market entry.

More information on the call and its requirements can be found on the dedicated website.

The call stays open until the capacity of the service providers is reached, and closes at the latest at the end of the TEF-Health project funding period on 31 December 2027.

Background: TEF-Health is a Digital Europe project coordinated by Charité Universitätsmedizin Berlin, Germany and comprises 52 partners from 9 European Union countries — each forming a so-called Node. The project is co-financed by national funding provided by Belgium, France, Germany, Portugal, Slovakia and Sweden.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1983 articles available search in articles 

Testimonial

ERC grants awarded to professor Inez Germeys

Professor Inez Germeys leads the Center for Contextual Psychiatry at KU Leuven, which is a large multi-disciplinary research group focusing on the interaction between the person and the environment in the development of psychopathology. She has received a European Research Council (ERC) Consolidator grant (INTERACT) and Proof of Concept grant (IMPACT). With these grants professor Germeys and her team researched a new mobile self-management therapy for patients with a psychotic disorder. The Acceptance and Commitment Therapy in Daily Life (ACT-DL) was further developed for the clinical environment. In line with that the Horizon 2020 IMMERSE project aims to thoroughly evaluate strategies, processes, and outcomes of implementing a digital mobile mental health solution.